Copyright 2008 Medical News Today Latest Lymphoma / Leukemia News From Medical News Today. http://www.medicalnewstoday.com/sections/lymphoma-leukemia/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Mon, 13 Oct 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/125227.php National Institutes of Health (NIH) scientists have identified a protein that plays matchmaker between two key types of white blood cells, T and B cells, enabling them to interact in a way that is crucial to establishing long-lasting immunity after an infection. Immune System / Vaccines Sun, 12 Oct 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/125130.php lCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) announced today the completion of enrollment as per protocol in the Phase 2 clinical trial of sapacitabine, the Company's oral nucleoside analogue, in elderly patients with acute myeloid leukemia (AML). Interim results from this trial are expected to be available by the end of 2008 and final results during the second half of 2009. Lymphoma / Leukemia Sun, 12 Oct 2008 00:00:00 PDT http://www.medicalnewstoday.com/articles/125144.php Investigators from the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine are focusing on a family of blood proteins that they hope holds a key to decreasing the toxic effects of chemotherapy in children and adults. Their findings may one day help in the development of targeted therapies for leukemia, multiple myeloma and other cancers of the blood. The researchers, led by Kristin T. Chun, Ph.D. Lymphoma / Leukemia Sat, 11 Oct 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/125164.php Genentech, Inc. (NYSE: DNA) and Biogen Idec (Nasdaq: BIIB) today announced that a global Phase III study of Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide chemotherapy met its primary endpoint of improving progression-free survival (PFS), as assessed by investigators, in patients with previously treated CD20-positive chronic lymphocytic leukemia (CLL) compared to chemotherapy alone. There were no new or unexpected safety signals reported in the study. Lymphoma / Leukemia Thu, 09 Oct 2008 08:00:00 PDT http://www.medicalnewstoday.com/articles/124946.php Texas Children's Cancer Center today launched Passport for Care, an innovative Web-based application that provides childhood cancer survivors and their physicians with immediate access to a survivor's diagnosis and treatment history. Passport for Care provides detailed, individualized health care recommendations based on the most up-to-date national survivorship care guidelines. Passport for Care inventor and Texas Children's Cancer Center director Dr. Cancer / Oncology Thu, 09 Oct 2008 06:00:00 PDT http://www.medicalnewstoday.com/articles/124935.php The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - today congratulated French researcher Dr. Luc Montagnier as co-recipient of the 2008 Nobel Prize in medicine. Dr. Lymphoma / Leukemia Thu, 09 Oct 2008 05:00:00 PDT http://www.medicalnewstoday.com/articles/124922.php A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules. Lymphoma / Leukemia Thu, 09 Oct 2008 05:00:00 PDT http://www.medicalnewstoday.com/articles/124924.php Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern. The phenotype and the characteristics of Hodgkin lymphoma cells are therefore unique. Björn Lamprecht and Dr. Lymphoma / Leukemia Thu, 09 Oct 2008 05:00:00 PDT http://www.medicalnewstoday.com/articles/124931.php EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that the European Commission has granted a full marketing authorization in the form of a positive Commission Decision, for Ceplene® (histamine dihydrochloride) for the remission maintenance and prevention of relapse in adult patients with Acute Myeloid Leukemia (AML) in first remission. Ceplene is to be administered in conjunction with low-dose interleukin-2 (IL-2). Lymphoma / Leukemia Tue, 07 Oct 2008 09:00:00 PDT http://www.medicalnewstoday.com/articles/124561.php New research suggests that the identification and examination of key cell signaling events required for initiation and progression of cancer might be best accomplished at the single cell level. The research, published by Cell Press in the October issue of the journal Cancer Cell, provides new insight that may lead to better diagnosis and treatment of some complex cancers. Cancer / Oncology Tue, 07 Oct 2008 09:00:00 PDT http://www.medicalnewstoday.com/articles/124564.php Celgene International Sarl (NASDAQ: CELG) announced that its oral cancer drug REVLIMID (lenalidomide) has received marketing authorization approval from Health Canada for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy. Multiple myeloma is the second most commonly diagnosed blood cancer worldwide. Approximately 6,000 Canadians have the disease and another 2,000 are diagnosed each year. Lymphoma / Leukemia Tue, 07 Oct 2008 06:00:00 PDT http://www.medicalnewstoday.com/articles/124525.php Genentech, Inc. (NYSE:DNA) and Biogen Idec (Nasdaq:BIIB) announced that a global Phase III study of Rituxan® (rituximab) in combination with fludarabine and cyclophosphamide chemotherapy met its primary endpoint of improving progression-free survival (PFS), as assessed by investigators, in patients with previously treated CD20-positive chronic lymphocytic leukemia (CLL) compared to chemotherapy alone. There were no new or unexpected safety signals reported in the study. Lymphoma / Leukemia Tue, 07 Oct 2008 06:00:00 PDT http://www.medicalnewstoday.com/articles/124527.php A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco. The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous molecular conversations, is likely to extend to many other disorders in which cell-signaling pathways are disrupted. Lymphoma / Leukemia Tue, 07 Oct 2008 04:00:00 PDT http://www.medicalnewstoday.com/articles/124495.php Come to the Bone Marrow Donor Drive and Become a Life-Saver DKMS, Whole Foods and the Deerfield community are joining forces to help save the life of Jon Simon, a Deerfield resident of 30 years, whose only chance of survival is a bone marrow transplant.  So far, no matches have been found. Jon, a devoted husband and father, has been fighting Non-Hodgkin Lymphoma (NHL), a type of blood cancer, for more than one year. Lymphoma / Leukemia Mon, 06 Oct 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/124291.php The International Myeloma Foundation (IMF)-supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians- announced that Susie Novis, president and co-founder of the IMF, has received the Wellsphere Health Impact Award for providing outstanding support and education to myeloma patients and caregivers, and driving innovation in the field of myeloma treatment. Lymphoma / Leukemia Fri, 03 Oct 2008 05:00:00 PDT http://www.medicalnewstoday.com/articles/124166.php Genentech, Inc. (NYSE:DNA), GlycArt, a company wholly-owned by Roche, and Roche (SWX:ROG) have entered into a collaboration agreement, including a license from GlycArt to Genentech, for the joint development and commercialization of GlycArt's GA101 molecule. Lymphoma / Leukemia Fri, 03 Oct 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/124046.php As part of a comprehensive R&D effort to develop an analytic tool to assist in accurately identifying leukemia stem cells, Oerlikon Leybold Vacuum is supporting the StemSpec R&D project at the University of Toronto with a TURBOVAC SL turbomolecular vacuum pump and a fore vacuum pump, and advising researchers about the use of the pumps. Lymphoma / Leukemia Wed, 01 Oct 2008 05:00:00 PDT http://www.medicalnewstoday.com/articles/123744.php The International Myeloma Foundation (IMF) - supporting research and providing education, advocacy, and support for myeloma patients, families, researchers, and physicians - today heralded the expansion of treatment options for previously untreated patients with multiple myeloma, giving patients in Canada and Europe access to drugs similar to what is available to patients in the United States. Lymphoma / Leukemia Wed, 01 Oct 2008 03:00:00 PDT http://www.medicalnewstoday.com/articles/123700.php The British Lymphology Society (BLS), the only UK body representing the medical professionals who treat lymphoedema, has chosen Belfast as the venue for its high profile annual conference. Nearly 200 nursing and physiotherapy delegates, plus 11 pharmaceutical companies will be gathering at the Wellington Park Hotel for three days; 5-7 October. Lymphoma / Leukemia Tue, 30 Sep 2008 02:00:00 PDT http://www.medicalnewstoday.com/articles/123482.php Virginia Commonwealth University Institute of Molecular Medicine and VCU Massey Cancer Center researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers. Lymphoma / Leukemia Mon, 29 Sep 2008 09:00:00 PDT http://www.medicalnewstoday.com/articles/123427.php Sports personality Gary Lineker visited the Royal Free Hospital in London on 24th September to meet the country's first Leukaemia CARE Clinical Nurse Specialist. Clara Patmore, who started in her new role at the Hampstead hospital this summer, is the first nurse in the UK to be funded by the charity Leukaemia CARE. Nursing / Midwifery Mon, 29 Sep 2008 09:00:00 PDT http://www.medicalnewstoday.com/articles/123428.php Know Your Nodes! That's the message the Lymphoma Association and Leukaemia CARE are spreading ahead of World Lymphoma Awareness Day (WLAD), an event held annually on September 15th which aims to inform the public about lymphoma; the sixth most common cancer in the UK. Lymphoma / Leukemia Mon, 29 Sep 2008 08:00:00 PDT http://www.medicalnewstoday.com/articles/123425.php New research has revealed we are more concerned about cancer now than we were 10 years ago - even though we know the outlook for anyone diagnosed with cancer today is more positive than ever1. Cancer / Oncology Mon, 29 Sep 2008 01:00:00 PDT http://www.medicalnewstoday.com/articles/123355.php A Macmillan Clinical Nurse Specialist in Haemato-Oncology has won an award for her 'Outstanding Contribution in Care and Support.' Debbie Gardiner, who works at St George's Hospital in London, received the Lymphoma Association's Beacon of Hope Award, where she was recognized for her dedication to patients and her hard work in setting up a local support group. Lymphoma / Leukemia Wed, 24 Sep 2008 12:00:00 PDT http://www.medicalnewstoday.com/articles/122884.php Lymphangiogenesis, the formation of new lymphatic vessels, has become a new research frontier. There is a crucial need for noninvasive methods to evaluate lymphangiogenesis in situ. However, to the best of our knowledge, lymphosonography about the tumour lymphangiogenesis with percutaneous hepatic injection of ultrasound contrast material was not reported before. A research article published in the World Journal of Gastroenterology addresses this problem. Lymphoma / Leukemia